weight loss

Penn researchers use AI to flag side effects discussed by GLP-1 users
PHILADELPHIA - A new study from the University of Pennsylvania suggests that artificial intelligence may help identify potential side effects of popular GLP‑1 weight‑loss drugs that are being discussed online, but may not appear in clinical trial data.
More Stories
More Stories
